104 related articles for article (PubMed ID: 35779946)
1. Cardiovascular Implications of microRNAs in Coronavirus Disease 2019.
Izzo C; Visco V; Gambardella J; Ferruzzi GJ; Rispoli A; Rusciano MR; Toni AL; Virtuoso N; Carrizzo A; Di Pietro P; Iaccarino G; Vecchione C; Ciccarelli M
J Pharmacol Exp Ther; 2023 Jan; 384(1):102-108. PubMed ID: 35779946
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of cardiovascular manifestations of COVID-19: a narrative review.
Bilehjani E; Fakhari S; Farzin H; Tajlil A; Nader ND
Acta Cardiol; 2024 May; 79(3):267-273. PubMed ID: 37606350
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and cardiovascular disease in patients with chronic kidney disease.
Del Vecchio L; Balafa O; Dounousi E; Ekart R; Fernandez BF; Mark PB; Sarafidis P; Valdivielso JM; Ferro CJ; Mallamaci F
Nephrol Dial Transplant; 2024 Jan; 39(2):177-189. PubMed ID: 37771078
[TBL] [Abstract][Full Text] [Related]
4. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement.
Lenihan D; Carver J; Porter C; Liu JE; Dent S; Thavendiranathan P; Mitchell JD; Nohria A; Fradley MG; Pusic I; Stockerl-Goldstein K; Blaes A; Lyon AR; Ganatra S; López-Fernández T; O'Quinn R; Minotti G; Szmit S; Cardinale D; Alvarez-Cardona J; Curigliano G; Neilan TG; Herrmann J
CA Cancer J Clin; 2020 Nov; 70(6):480-504. PubMed ID: 32910493
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils.
Baldassarre LA; Yang EH; Cheng RK; DeCara JM; Dent S; Liu JE; Rudski LG; Strom JB; Thavendiranathan P; Barac A; Zaha VG; Bucciarelli-Ducci C; Ellahham S; Deswal A; Lenneman C; Villarraga HR; Blaes AH; Ismail-Khan R; Ky B; Leja MJ; Scherrer-Crosbie M
J Natl Cancer Inst; 2021 May; 113(5):513-522. PubMed ID: 33179744
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery.
Lazaridis C; Vlachogiannis NI; Bakogiannis C; Spyridopoulos I; Stamatelopoulos K; Kanakakis I; Vassilikos V; Stellos K
Hellenic J Cardiol; 2020; 61(6):381-395. PubMed ID: 32534109
[TBL] [Abstract][Full Text] [Related]
7. The long-term cardiovascular impairment of COVID 19: need for clarity in definition and terminology.
Calcaterra G; Bassareo PP; Spaccarotella CA; Barillà F; Sciomer S; Vadalà G; de Gregorio C; Romeo F; Mehta JL; Mattioli AV
Minerva Cardiol Angiol; 2024 Feb; 72(1):24-31. PubMed ID: 37705368
[TBL] [Abstract][Full Text] [Related]
8. Cardiac damage and tropism of severe acute respiratory syndrome coronavirus 2.
Tangos M; Jarkas M; Akin I; El-Battrawy I; Hamdani N
Curr Opin Microbiol; 2024 Apr; 78():102437. PubMed ID: 38394964
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection.
Judson GL; Kelemen BW; Njoroge JN; Mahadevan VS
Cardiol Ther; 2020 Dec; 9(2):293-305. PubMed ID: 32535752
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129.
Badimon L; Robinson EL; Jusic A; Carpusca I; deWindt LJ; Emanueli C; Ferdinandy P; Gu W; Gyöngyösi M; Hackl M; Karaduzovic-Hadziabdic K; Lustrek M; Martelli F; Nham E; Potočnjak I; Satagopam V; Schneider R; Thum T; Devaux Y
Cardiovasc Res; 2021 Jul; 117(8):1823-1840. PubMed ID: 33839767
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention.
Iqubal A; Iqubal MK; Hoda F; Najmi AK; Haque SE
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1083-1092. PubMed ID: 33618607
[No Abstract] [Full Text] [Related]
12. Ginseng and ginsenosides on cardiovascular and pulmonary diseases; Pharmacological potentials for the coronavirus (COVID-19).
Vijayakumar A; Kim JH
J Ginseng Res; 2024 Mar; 48(2):113-121. PubMed ID: 38465214
[TBL] [Abstract][Full Text] [Related]
13. The complexity of cardiovascular long COVID: where we are.
Gandhi RS; Raman B
Cardiovasc Res; 2024 Jul; 120(8):e30-e32. PubMed ID: 38757616
[No Abstract] [Full Text] [Related]
14. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease.
Thakkar S; Arora S; Kumar A; Jaswaney R; Faisaluddin M; Ammad Ud Din M; Shariff M; Barssoum K; Patel HP; Nirav A; Jani C; Patel K; Savani S; DeSimone C; Mulpuru S; Deshmukh A
Clin Med Insights Cardiol; 2020; 14():1179546820977196. PubMed ID: 33312009
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 pandemic and the cardiovascular system: What the non-cardiologist needs to know.
Davis GK; Adlan A; Majewski J; Ibrahim B
Clin Med (Lond); 2020 May; 20(3):262-265. PubMed ID: 32354733
[TBL] [Abstract][Full Text] [Related]
16. miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome.
Jankovic M; Nikolic D; Novakovic I; Petrovic B; Lackovic M; Santric-Milicevic M
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980399
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular comorbidities and complications associated with coronavirus disease 2019.
Mahajan K; Chandra KS
Med J Armed Forces India; 2020 Jul; 76(3):253-260. PubMed ID: 32773926
[TBL] [Abstract][Full Text] [Related]
18. You can't prove what you believe: Response to a letter entitled "Cardiovascular events in the context of coronavirus disease 2019" from Lee et al.
Hermida A; Gabrion P; Beyls C
Arch Cardiovasc Dis; 2023; 116(8-9):427. PubMed ID: 37419723
[No Abstract] [Full Text] [Related]
19. Sex and Age: 2 Predictors of Cardiovascular Events With COVID-19 Infection.
Lundberg G; Toleva O; Cutchins A
JACC Adv; 2023 May; 2(3):100325. PubMed ID: 37250381
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of MicroRNAs in Vascular Disease.
Maegdefessel L
Curr Vasc Pharmacol; 2013 May; ():. PubMed ID: 23713858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
